Lathrop GPM Partner Michael Spellberg Ph.D.‘s presentation on Oligonucleotide Patenting Strategies for the 2025 UMass RNA Therapeutics Symposium.
Lathrop GPM Partner Michael Spellberg Ph.D.‘s presentation on Oligonucleotide Patenting Strategies for the 2025 UMass RNA Therapeutics Symposium.